stage i: registration
the registration stage is the first opportunity for applicants to describe their ideas that will enhance early detection, warning, and response to infectious diseases. the ideas should address the vision of ai4pep: deepen the understanding of how responsible ai solutions can improve public health preparedness and response. for example, the ideas could address one or more of the themes and or pillars described below. the ideas should be ambitious enough to sustain the active engagement of outstanding researchers for at least five years and should also have a longer-term vision. the applicants are required to have at least one knowledge user (either from industry, civil society or policy maker) as a partner (preferably co-applicant). we expect the knowledge users to be identified at this stage so as to encourage meaningful and authentic collaboration. after a review of registrations by a selected international panel of reviewers, all eligible registrations will be invited to submit a letter of intent (loi).

for more information, please contact jill sherman at intl.research@lakeheadu.ca.

n response to the truth and reconciliation commission of canada (trc) call to action 65, the reconciliation network in response to call to action 65 is a joint initiative between the national centre for truth and reconciliation (nctr) and sshrc. this unique opportunity supports establishment of a national research program with multiyear funding to advance collective understanding of reconciliation.

the trc defines “reconciliation” as an ongoing process of establishing and maintaining respectful relationships. the trc explained:

“[r]econciliation must support aboriginal peoples as they heal from the destructive legacies of colonization that have wreaked such havoc in their lives. but it must do even more. reconciliation must inspire aboriginal and non-aboriginal peoples to transform canadian society so that our children and grandchildren can live together in dignity, peace, and prosperity on these lands we now share.”

one of the nctr’s goals is to provide educational and employment opportunities to indigenous peoples. in alignment with this, and in keeping with the principles and strategic directions in sshrc’s indigenous research statement of principles and in the federal research funding agencies’ strategic plan, setting new directions to support indigenous research and research training in canada 2019-2022, this joint initiative is designated for research projects led by first nations, métis nation or inuit researchers as applicant / project director.

sshrc and the nctr invite teams led by first nations, métis nation or inuit researchers to submit proposals for new or existing formal partnerships that contribute to our collective understanding of truth and reconciliation. proposals could, for example, address residential schools’ history, or the ongoing legacy of residential schools and canada’s policies of assimilation in one or more areas, including child welfare, education, language and culture, health, and justice.

the trc noted closing residential schools did not end their impacts on indigenous peoples; indigenous peoples continue to experience systemic discrimination across sectors, which persists as part of government policies of assimilation and undermines reconciliation.

applicants interested in this funding opportunity are asked to contact the office of research (sshrc.research@lakeheadu.ca) far in advance of the sshrc deadline to indicate their interest in this program.

cqdm’s quantum leap pharma-led funding program for drug discovery research helps smes or canadian universities achieve innovative translational biopharmaceutical research projects. projects selected as part of the quantum leap program focus on developing cutting-edge technologies with the potential to significantly advance the r&d activities of cqdm’s pharmaceutical members. quantum leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

the enabling technologies, innovative platforms and/or innovative therapies derived from the quantum leap pharma-led funding program for drug discovery research are selected for their potential to significantly improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs. the technologies of interest can be at any stage of the drug development process and involve a wide range of therapeutic indications.

projects are associated with specific deliverables and must be ready for use by cqdm pharmaceutical members upon completion. for scientists, the funded research opens new collaboration opportunities with world-class stakeholders in the industry.

parkinson canada is pleased to offer its graduate student award program (the “program”) as a strategic initiative to encourage promising young scientists to enter the field of parkinson's research and to invest in research training that offers promise for future work in the area of parkinson’s disease.    through this initiative, parkinson canada thus invites 世界杯2022赛程表淘汰赛 hip applications (“applications”) from those currently enrolled in a phd program committed to conducting research relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders.  overall, this initiative is consistent with, and reflects, parkinson canada’s commitment to support innovation and renewal in the national parkinson’s research field and to foster international leadership potential in this area.

parkinson canada is pleased to offer its basic research fellowship program (the “program”) as a strategic initiative to encourage promising young scientists to enter the field of parkinson's research and to invest in research training that offers promise for future work in the area of parkinson’s disease. through this initiative, parkinson canada invites fellowship applications (“applications”) from applicants committed to  conducting research relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders. this initiative is consistent with, and reflects, parkinson canada’s commitment to support innovation and renewal in the national parkinson’s research field and to foster international leadership potential in this area. 

parkinson canada is pleased to offer its clinical research fellowship program (the “program”) as a strategic initiative to encourage promising young scientists to enter the field of parkinson's clinical research and to invest in research training that offers promise for future work in the area of parkinson’s disease. through this initiative, parkinson canada thus invites fellowship applications from applicants committed to conducting research relevant to the cure, cause, prevention, improved treatment and/or understanding of parkinson’s disease or related disorders. this initiative is consistent with, and reflects, parkinson canada’s commitment to support innovation and renewal in the national parkinson’s research field and to foster international leadership potential in this area.  funds awarded under the program are to be used to cover salary, benefits and expenses for clinical research fellowships in parkinson's-related areas.

parkinson canada is pleased to offer the clinical movement disorders fellowship (the “program”) as a strategic initiative to encourage promising young clinicians to enter clinical training in the subspecialty of movement disorders, which will include parkinson’s disease. the purpose of this post-residency training is to provide expertise in the diagnosis and management of parkinson’s disease and may include other movement disorders.  clinical training is the largest component of this hands-on program (at least 80%) but could include an element of research.  however, this application will be evaluated solely on the clinical component.  parkinson canada wishes to ensure that each canadian with parkinson’s receives appropriate medical expertise, drug treatment, continuous care, education, respect, dignity, help and hope.  this program is an important component of parkinson canada’s plan to achieve its goal of ensuring that these critical elements in the day-to-day management of parkinson’s disease are accessible and available